Pharmaceuticals: Demo Covers Recurrent Breast Cancer Drugs
Officials say there's lots of spots left in demo.Medicare has expanded the coverage guidelines for providers participating in one of its drug demonstration projects. The Medicare Replacement Drug Demonstration project will cover drugs for all patients with recurrent breast cancer, as well as patients with breast cancer of stage two to four, CMS officials revealed at Medicare's June 7 Physician Open Door Forum. The demonstration has enrolled over 29,000 people but still has lots of room for more, CMS officials said.
...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4200 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.